MAPT and Alzheimer disease: For example, tau pathology, as revealed with tau monoclonal antibodies AT8 or PHF-1 (PHF-tauAT8 and PHF-tauPHF-1), shows different patterns of immunostaining in different AD patients that could be interpreted as steps of the progression of the disease.